selumetinib
Drug Details
- Generic Name
- selumetinib
- Brand Names
- N/A
- Application Number
- Sponsor
- Patheon Pharmaceuticals Inc.
- NDC Codes
- 2
- Dosage Forms
- CAPSULE
- Routes
- N/A
- Active Ingredients
- SELUMETINIB
Indications and Usage
1 INDICATIONS AND USAGE KOSELUGO is indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) [see Dosage and Administration (2) ]. KOSELUGO is a kinase inhibitor indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). ( 1 )